======= POLE4 ======= == Gene Information == * **Official Symbol**: POLE4 * **Official Name**: DNA polymerase epsilon 4, accessory subunit * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56655|56655]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NR33|Q9NR33]] * **Interactions**: [[https://thebiogrid.org/search.php?search=POLE4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20POLE4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607269|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May play a role in allowing polymerase epsilon to carry out its replication and/or repair function. |Histone| |CBFD NFYB HMF| |epsilon DNA polymerase complex| |Ada2/Gcn5/Ada3 transcription activator complex| |telomere maintenance via semi-conservative replication| |DNA-directed DNA polymerase activity| |DNA replication initiation| |nuclear DNA replication| |cell cycle DNA replication| |histone H3 acetylation| |telomere maintenance| |telomere organization| |DNA biosynthetic process| |histone acetylation| |internal peptidyl-lysine acetylation| |G1/S transition of mitotic cell cycle| |DNA-dependent DNA replication| |cell cycle G1/S phase transition| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |protein acetylation| |protein acylation| |DNA replication| |mitotic cell cycle phase transition| |cell cycle phase transition| |peptidyl-lysine modification| |anatomical structure homeostasis| |histone modification| |covalent chromatin modification| |protein heterodimerization activity| |mitotic cell cycle process| |mitotic cell cycle| |chromatin organization| |DNA metabolic process| |peptidyl-amino acid modification| |cellular homeostasis| |cell cycle process| |chromosome organization| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |cell cycle| |DNA binding| |cellular nitrogen compound biosynthetic process| |homeostatic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-2.64| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|-2.42| |[[:results:exp350|Deferoxamine 11μM R07 exp350]]|-2.04| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-1.88| |[[:results:exp270|Campthothecin 0.001μM R06 exp270]]|-1.86| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|1.9| ^Gene^Correlation^ |[[:human genes:p:pole3|POLE3]]|0.617| |[[:human genes:c:chtf8|CHTF8]]|0.424| |[[:human genes:c:cyb561a3|CYB561A3]]|0.404| Global Fraction of Cell Lines Where Essential: 8/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|2/25| |breast|0/33| |central nervous system|1/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|3/21| |liver|0/20| |lung|1/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|1/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1296 * **Expression level (log2 read counts)**: 3.46 {{:chemogenomics:nalm6 dist.png?nolink |}}